Seeking Alpha

Advanced Cell Technology (ACTC.OB) receives approval from an independent Data & Safety...

Advanced Cell Technology (ACTC.OB) receives approval from an independent Data & Safety Monitoring Board to proceed with the next stage of three stem cell studies in the U.S. and Europe in people with the vision disorders Stargardts Macular Dystrophy and dry age-related macular degeneration. The two trials in the U.S. can include patients with better vision than previously allowed. (PR)
Comments (5)
  • Excellent news!
    14 Mar 2013, 10:11 AM Reply Like
  • This is the best thing that could have happened. After a year and a half of research, I decided to buy 15,000 shares of stock in ACTC, and I'll probably put in another 60,000 soon. (It's penny stock-- so that's not as impressive as it sounds! ;) This is the stock opportunity that everyone is missing because you need to do so much research to see how valuable it will become. I predict a 10,000 percent increase in value within five years-- and maybe even more.


    The funny part is that there's literally NO way to tell people about this so that it doesn't sound like spam!!
    14 Mar 2013, 11:42 AM Reply Like
  • I'm right there with you Anise. I try to tell people but they'll say it's pump & dump or a shell company. Oh well. Gonna hold my shares.
    14 Mar 2013, 08:23 PM Reply Like
  • As an AMD sufferer my vision declines daily. It is probably less than a yr before I can't drive. PLEASE ACT be successful quickly.
    14 Mar 2013, 12:39 PM Reply Like
  • Im looking onto ACTC.. What is the latest?
    14 Oct 2013, 05:12 PM Reply Like
DJIA (DIA) S&P 500 (SPY)